EPO Patents = 2

Forward Citations = 0

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

24 inventors (with patents filed for the assignee):

Yuchuan Wu (3 out of 6 patents)

Yonghan Hu (2 out of 5 patents)

Xiao Xi Liu (1 out of 62 patents)

4. Xi Chen (1 out of 151 patents)

5. Shaoqiang Huang (1 out of 7 patents)

6. Xin Li (1 out of 10 patents)

7. Dongdong Wu (1 out of 9 patents)

8. Yonghui Wang (1 out of 2 patents)

9. Yan Zhu (1 out of 1 patent)

10. Juan Zhou (1 out of 2 patents)

11. Shiqun Wang (1 out of 1 patent)

12. Yujun Gao (1 out of 3 patents)

13. Dong Wang (1 out of 4 patents)

14. Wandeng Liu (1 out of 1 patent)

15. Ximing Shen (1 out of 4 patents)

4 patents: Sort by Forward Citations

1. 11591342 - Heterocyclic compound, application thereof and pharmaceutical composition comprising same (2023-02-28),

2. 11078202 - β-lactamase inhibitor and use thereof (2021-08-03),

3. 10882843 - 5-aminopyrazole carboxamide derivative as BTK inhibitor and preparation method and pharmaceutical composition thereof (2021-01-05),

4. 10821104 - Five-membered heterocyclic amides WNT pathway inhibitor (2020-11-03),

Suzhou Sinovent Pharmaceuticals Co., Ltd. is a leading pharmaceutical company based in Suzhou, China. We specialize in research, development, and production of innovative and high-quality pharmaceutical products. With a focus on meeting the healthcare needs of our customers, we strive to bring cutting-edge solutions to the market. Our commitment to excellence and dedication to customer satisfaction set us apart in the industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#35 in Province

#5,525 in China

Province, China

Suzhou Sinovent Pharmaceuticals Co., Ltd.